You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科笛-B(02487.HK):CU-30101(局部外用利多卡因丁卡因乳膏劑)中國III期臨牀試驗結果獲第三十次CSD年會接受以電子壁報形式展示
格隆匯 06-27 06:32

格隆匯6月27日丨科笛-B(02487.HK)發佈公告,集團用於表皮麻醉手術的CU-30101(局部外用利多卡因丁卡因乳膏劑)的中國III期臨牀試驗(“該III期臨牀試驗”)結果獲中華醫學會第三十次皮膚性病學術年會(“CSD年會”)接受以電子壁報形式展示。這是集團的研究成果連續兩屆入選CSD年會,代表了集團在皮膚科領域的行業影響力及前沿水準。

該III期臨牀試驗爲一項多中心、隨機、雙盲、陽性藥對照、配對設計的臨牀試驗,以評估CU-30101用於表皮麻醉手術局部鎮痛的安全性及療效。該III期臨牀試驗以參比製劑Pliaglis®利多卡因丁卡因乳膏(“Pliaglis®”)作爲對照,主要療效終點爲點陣激光術後即刻疼痛視覺模擬評分(“VAS”),並同時對不良事件和局部皮膚耐受性進行了評估。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account